Back

Targeting inflammation and immunity in cardiovascular disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Emerging therapeutic frontiers in cardiology: what does the future hold? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Peter Libby

Mass General Brigham, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
From data to discovery of new therapies: can multiomics transform cardiovascular medicine?
Professor K. Stellos (Heidelberg, DE)
Slides Video
Presentation thumbnail
Metabolic reprogramming as a therapeutic target in cardiovascular disease: from mechanisms to regeneration
Professor Y. Wang (Singapore, SG)
Slides Video
Presentation thumbnail
SGLT2 inhibitors and heart failure: mechanisms and clinical implications
Professor S. Verma (Toronto, CA)
Slides Video
Presentation thumbnail
Emerging therapeutic frontiers in cardiology: what does the future hold? - discussion
Video

Access the full session

Session thumbnail
Emerging therapeutic frontiers in cardiology: what does the future hold?
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Anti-inflammatory therapies: from bench to bedside
thumbnail
Congress Session
Inflammation: the next target in atherosclerotic cardiovascular disease care?
thumbnail
Congress Session
Unravelling cardiovascular inflammation in atherosclerotic cardiovascular disease (ASCVD): from evidence to guidance

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources